From DCAT Value Chain Insights (VCI)
Genmab has appointed Judith Klimovsky, MD, as executive vice president and chief development officer, who will lead the company's global product development activities. Dr. Klimovsky will join the executive team of the chief executive officer, Dr. Jan van de Winkel, and chief financial officer, David Eatwell.
Dr. Klimovsky joined Genmab in February 2017 and will be based at the company's Princeton, New Jersey location. Dr. Klimovsky most recently served as senior vice president and global head, Oncology Clinical Development at Novartis. She has previously served in senior roles at Merck and Bristol-Myers Squibb. Dr. Klimovsky has also held positions in clinical practice in Buenos Aires, Argentina.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription